A medicine for treating cardiovascular and cerebrovascular disease
A technology for cardiovascular and cerebrovascular diseases and medicines, applied in the field of medicines composed of effective parts, can solve the problems that the quality of medicines cannot be strictly controlled, the production of imitation can not be random, and the hidden dangers of clinical medicine safety, so as to reduce ischemia-reperfusion injury, Good curative effect, effect of enhanced effect
Active Publication Date: 2010-09-15
CHENGDU YILUKANG MEDICAL TECH & SERVICE
View PDF4 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0009] Some new varieties of drugs for the treatment of cardiovascular and cerebrovascular diseases developed and marketed abroad in the 1990s cannot be imitated and produced at will in China because they involve the protection of invention patents of foreign companies, so they can only rely on imports to meet domestic clinical urgent needs
[0010] At the same time, the above drugs often have the following toxic and side effects: slow heart rate, fatigue, dry mouth, chest tightness, etc., often accompanied by abnormal phenomena such as headache, facial flushing, ankle edema, etc. Some drugs can even cause liver damage and muscle dissolution, etc. serious side effects
[0011] The existing Western medicines for the treatment of cardiovascular and cerebrovascular diseases have various side effects. Traditional Chinese medicines are more and more concerned by medical researchers and patients because of their significant curative effect, stability and reliability, and small toxic and side effects. However, most of the existing Chinese medicines are multi-flavor The medicinal material formula is made, because it is a crude extract, the onset of effect is slow, and the patient takes a large amount, which leads to a large waste of medicinal material resources, and the active ingredients are not clear, and the quality of the drug cannot be strictly controlled. cause safety hazard
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0050] Take 10 g of acetaloflavones, 1 g of total saponins of Panax notoginseng, and 25 g of vegetable oil, mix them evenly, use gelatin as the capsule shell material, and press them into soft capsules to obtain a soft capsule dosage form containing 1 part of acetaloflavones and 0.1 part of total saponins of notoginseng medicine.
Embodiment 2
[0052] Take 1 g of acetaloflavone and 20 g of total saponins of Panax notoginseng, dissolve them in 1000 ml of water for injection, and adopt the existing powder injection preparation process to obtain a medicine in powder injection form containing 1 part of acetaloflavone and 20 parts of total saponins of notoginseng.
Embodiment 3
[0054] Get 5 g of acetaloflavone, 5 g of total saponins of Panax notoginseng, and 90 g of starch, mix them evenly, and adopt a capsule preparation process to obtain a medicine in the form of a hard capsule containing 1 part of acetaloflavone and 1 part of total saponins of Panax notoginseng.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention discloses a medicament for treating cardiovascular and cerebrovascular diseases, wherein the raw material includes the constituents of hippophe flavone 1 part, Notoginsen triterpenes 0.1-20 parts.
Description
Technical field [0001] The invention relates to a medicine for treating cardiovascular and cerebrovascular diseases, specifically the medicine composed of effective parts of sea buckthorn and notoginseng. Background technique [0002] Cardiovascular and cerebrovascular diseases such as coronary heart disease, cerebral infarction, and cerebral apoplexy are common diseases that seriously endanger human life and health. According to the report of the World Health Organization, 1 of every 3 deaths in the United States is caused by cardiovascular and cerebrovascular diseases. More than half a million people died of myocardial infarction. Cardiovascular and cerebrovascular diseases have become the number one killer of human health, and their morbidity and mortality have surpassed those of tumor diseases and rank first. Most patients need to take medicine for life. Statistics show that the world's cardiovascular and cerebrovascular drug market sales in 2000 were nearly 50 billion ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/704A61K36/258A61K9/00A61P9/10
Inventor 罗蜀蓉林辉
Owner CHENGDU YILUKANG MEDICAL TECH & SERVICE